tirzepatide updates FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Update Part 2: Breastfeeding

MK-677 and IGF-1 Downstream of GH, the liver and other tissues produce insulin-like growth factor 1 (IGF-1), which mediates many of GHs anabolic effects and provides a stable, integrated readout of GH exposure

No, GLP-1s are considered adjunctsthey do not replace disease-modifying drugs but can be a helpful addition in select patients to improve metabolic and inflammatory status.

Symptoms of hypoglycaemia include tremor, sweating, confusion, palpitations, and in severe cases, loss of consciousness or seizures

Retatrutides triple-receptor approach (GLP-1 + GIP + glucagon) delivered 28.7% weight loss in Phase 3 and addresses energy expenditure in ways that neither Semaglutide, Cagrilintide, or even Tirzepatide can touch

doi: 10.1159/000326785